Početna › Ulcerativni kolitis
Kliničke studije za Ulcerativni kolitis koje traže sudionike u SAD-u
79 studija za Ulcerativni kolitis traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- New York City, NY23 studija
- Orlando, FL22 studija
- Miami, FL21 studija
- Houston, TX17 studija
- San Antonio, TX16 studija
- Chicago, IL15 studija
- Tacoma, WA15 studija
- San Diego, CA15 studija
- Tyler, TX14 studija
- Colorado Springs, CO14 studija
- Los Angeles, CA13 studija
- St. Louis, MO13 studija
- Washington, DC12 studija
- Boston, MA11 studija
- Cincinnati, OH11 studija
- Providence, RI11 studija
- Louisville, KY10 studija
- Parma, OH10 studija
- Lewisville, TX10 studija
- Durham, NC10 studija
- Tampa, FL9 studija
- Lubbock, TX9 studija
- Evanston, IL9 studija
- Atlanta, GA9 studija
- Baltimore, MD8 studija
- Mountain View, CA8 studija
- Scottsdale, AZ8 studija
- Garland, TX8 studija
- Round Rock, TX8 studija
- Memphis, TN8 studija
- Metairie, LA8 studija
- Dallas, TX8 studija
- Seattle, WA8 studija
- Cleveland, OH8 studija
- Waukegan, IL7 studija
- Pittsburgh, PA7 studija
- Fort Worth, TX7 studija
- Charlotte, NC7 studija
- Anaheim, CA7 studija
- Wyoming, MI7 studija
Po državama
- Alabama7 studija
- Arizona19 studija
- Arkansas4 studija
- Colorado17 studija
- Connecticut11 studija
- Distrikt Columbia3 studija
- Florida31 studija
- Georgia14 studija
- Idaho4 studija
- Illinois24 studija
- Indiana10 studija
- Kalifornija39 studija
- Kansas10 studija
- Kentucky13 studija
- Louisiana15 studija
- Maryland13 studija
- Massachusetts16 studija
- Michigan17 studija
- Minnesota8 studija
- Mississippi6 studija
- Missouri16 studija
- Nevada6 studija
- New Hampshire5 studija
- New Jersey7 studija
- New York30 studija
- North Carolina23 studija
- Ohio26 studija
- Oklahoma4 studija
- Oregon5 studija
- Pennsylvania12 studija
- Rhode Island11 studija
- South Carolina12 studija
- South Dakota4 studija
- Tennessee12 studija
- Texas33 studija
- Utah7 studija
- Virginia14 studija
- Washington22 studija
- Wisconsin4 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
U tijeku regrutacijaOpažajna studija
Od 18 do 85 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07619547Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
U tijeku regrutacijaFaza 3
Sve dobne skupine · Oba spola · Ažurirano 2. lis 2026. · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 16 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06979336Immune Regulation in Ulcerative Colitis or Crohn s Disease
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
1 Day – 75 Years · Oba spola · Ažurirano 28. ruj 2026. · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
U tijeku regrutacijaFaza 3
Od 3 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
U tijeku regrutacijaFaza 2/3
Od 2 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07513181Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.